Preventive antiretroviral therapy in non-thalassemia carrier infants exposed to mother-to-child transmission of hiv decreases cord and after delivery red blood production without altering the development of hemoglobin

• Main Authors: Pornprasert,S., Wongnoi,R., Oberdorfer,P., Sirivatanapa,P.
• 格式: Article
• 出版: Bentham Science Publishers B.V. 2015
• 主題: Infectious Diseases; Virology
• 在線閱讀: http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84906226855&origin=inward; http://cmuir.cmu.ac.th/handle/6653943832/38123

Antiretroviral (ARV) prophylaxis for prevention of mother to child transmission (MTCT) of HIV could affect hemoglobin (Hb) development of infants. A cross-sectional descriptive study was conducted in 24 HIV-infected and 21 HIV-uninfected pregnancies. ARV drugs were administered to HIV-infected pregn...